20 March 2008: Dr Nadia Peviani, CEO of Temas, Appointed to CM&D Advisory Board Chertsey, 20th March 2008. CM&D Pharma Limited, the European niche specialty company, today announced the appointment of Dr Nadia Peviani, CEO and owner, Temas srl to its Advisory Board. A graduate in biology, Dr Peviani trained academically and professionally in pharmaceutical Regulatory Affairs, gaining valuable experience both in the corporate environment and as a private consultant.  This included a period at SmithKline Beecham (later gsk), where she rose to the position of Regulatory Affairs Manager and Head of Project Management. In 1994, Nadia established Temas, one of the largest healthcare regulatory consulting companies in Italy, which has gained an impressive international reputation.  An active member of several professional societies (including TOPRA and SSFA) and a coordinator of training for the Forum Institute, Dr Peviani brings to the Advisory Board an advanced perspective on European regulatory matters, as well as a strategic view of future developments. Danilo Casadei Massari, Corporate Development Director of CM&D said: ‘As CM&D is operating across a range of regulatory areas, the strategic outlook which Dr Peviani brings to our Advisory Board will be extremely valuable.  Her day-to-day exposure to a complex field has given her a strong appreciation of the challenges that we face.’ Further information:  Danilo Casadei Massari, +44 1932 895090, massari@cmdpharmaltd.com > Back